Codexis Inc.

(CDXS) Trade

By |

Profile

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases etc. The company operates in two business segment namely Performance Enzymes and Novel Biotherapeutics.

Contact Information

Website: www.codexis.com
Email: jcain@lhai.com
Main Phone: +1 650 421-8100
Address: 200 Penobscot Drive
State: CA
City / Town: Redwood City
Country: USA
Postal Code: 94063

Issuer Information

Exchange: NGS
CEO: John J. Nicols
Employees: 161
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

Profile

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases etc. The company operates in two business segment namely Performance Enzymes and Novel Biotherapeutics.

Contact Information

Website: www.codexis.com
Email: jcain@lhai.com
Main Phone: +1 650 421-8100
Address: 200 Penobscot Drive
State: CA
City / Town: Redwood City
Country: USA
Postal Code: 94063

Issuer Information

Exchange: NGS
CEO: John J. Nicols
Employees: 161
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

$ 13.29 $ -0.13 (-0.97%)
Last Price 13.29 Change $ -0.13 Change % -0.97 Tick N/A
Bid 13.28 Bid Size 1,200.00 Ask 13.30 Ask Size 300.00
Open 13.30 High 13.42 Low 13.22 Prev Close 13.42
Last Trade Volume 61,978 52 Wk Hi 18.88 52 Wk Low 8.44
Market Cap 785.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 59,126,820.00 EPS (TTM) -0.24 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 29 33
Number of Buys 14 14
Number of Sells 15 19
Net Activity -66231 -195087
Last 10 Buys Shares
Patrick Y. Yang 1,000
Patrick Y. Yang 1,000
Patrick Y. Yang 1,000
Patrick Y. Yang 1,000
John J. Nicols 1,000
John J. Nicols 1,000
John J. Nicols 1,000
Robert J. Lawson 1,000
Last 10 Sell Shares
Dennis P. Wolf 1,000
John J. Nicols 1,000
John J. Nicols 1,000
Gordon Sangster 1,000
Pam Cheng 1,000
Pam Cheng 1,000
Pam Cheng 1,000
Michael D. Aldridge 1,000
James Lalonde 1,000
James Lalonde 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 16 15.5 15.5 16
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 13.88 13.17 13.17 13.88
Standard Deviation 3.28 3.62 3.62 3.28
Date of Most Recent Estimate 06/04/18 05/14/18 05/14/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1